Formulation and evaluation of transdermal drug delivery system of verapamil hydrochloride

Authors

  • S C Marapur Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.
  • D S Wali Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.
  • B S Hunasagi Dept. of Pharmacognosy, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.
  • M Chetankumar Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.
  • R G Patil Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

Abstract

The aim of this research was to develop and evaluate a matrix type of transdermal drug delivery system containing Verapamil Hydrochloride. The series of formulations containing Verapamil Hydrochloride were formulated by using different polymers like HPMC (hydrophilic), CAP (hydrophobic) and EC (hydrophobic) in different ratios by solvent evaporation technique. Propylene glycol and Dibutyl phthalate were used as plasticizers. The 20% and 40% of DMSO is used as the penetration enhancer. Formulated transdermal patches were physically evaluated for thickness, weight variation, drug content, flatness, tensile strength, folding endurance, and water vapour transmission rate. The in-vitro drug release study was carried out by using Franz diffusion cell. The data obtained from release study shows increased percentage of drug permeated in 20% of DMSO containing formulation than 40% of DMSO containing formulation. Drug permeation is enhanced in the formulation containing high concentration of HPMC (VH1). The VH2 and VH6 helped in maintaining the rate of release at a constant level (20% DMSO). But in case of 40% DMSO is used as the concentration of CAP increases the rate of permeation increases. Skin irritation study does not show any irritation on the skin of rabbit. There is no possible interaction between drug and polymers in FITR as well as DSC. XRD of selected formulation shows that drug present in the formulation is in crystalline form.

Keywords: Verapamil HCl, HPMC, EC, CAP, DMSO, TDDS, Solvent evaporation

DOI

https://doi.org/10.22270/jddt.v8i6-s.2081

Author Biographies

S C Marapur, Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

D S Wali, Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

B S Hunasagi, Dept. of Pharmacognosy, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

Dept. of Pharmacognosy, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

M Chetankumar, Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

 Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

R G Patil, Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

Dept. of Pharmaceutics, BLDEA’s SSM College of Pharmacy and Research centre, B.L.D.E. University campus, Vijayapur-586 103, Karnataka, India.

References

Upadhyay G, Verma S, Parvez N, Sharma PK. Recent trends in transdermal drug delivery system - a review. Advances in Biological Research. 20148; (3):131-138. DOI: 10.5829/idosi.abr.2014.8.3.8446

J Ashok kumar1, Pullakandam1 N, S Lakshmana prabu, V Gopal. Transdermal drug delivery system: an overview. July – August 2010; 3(2):49-54.

Bhowmik D, Rao KP, Duraivel S, Sampath Kumar KP. Recent approaches in transdermal drug delivery system. IC Journal No: 7725, 2013; 2(3):99-108.

Prashar M, Aggarwal G, Harikumar SL. Formulation and evaluation of transdermal drug delivery system of Simvastatin using natural and synthetic permeation enhancers. Der Pharmacia Lettre. 2014; 6 (5):358-368.

Patel HV, Bhatt JD, Patel NK. Design and development of transdermal drug delivery for anti-hypertensive drug using different polymeric system. International journal of pharmaceutical and chemical sciences 2013; 2(2):492-494.

Hafeez A, Dr Jain U, Singh J, Maurya A, Rana L Recent advances in transdermal drug delivery system (tdds): an overview. Journal of Scientific and Innovative Research. 2013; 2(3):695-709

Rao NR, Askulla S, Bhavya B, Prasoona Ch, Koppu P. Design and evaluation of glipizide transdermal patches. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2011; 2(4):1620-1633

Bangale GS, Rathinaraj BS, Rajesh KS, Shinde GV, Umalkar DG, Rajveer CH et.al, Design and evaluation of transdermal films of atenolol. J. Chem. Pharm. Res. 2010; 2(3):593-604.

Sood J, Kaur V, Pawar P. Transdermal delivery of verapamil hcl: effect of penetration agenton in vitro penetration through rat skin. Journal of Applied Pharmaceutical Science. 2013; 3(03):044-051. DOI: 10.7324/JAPS.2013.30309

Published

15-12-2018
Statistics
Abstract Display: 752
PDF Downloads: 728

How to Cite

1.
Marapur SC, Wali DS, Hunasagi BS, Chetankumar M, Patil RG. Formulation and evaluation of transdermal drug delivery system of verapamil hydrochloride. J. Drug Delivery Ther. [Internet]. 2018 Dec. 15 [cited 2025 Apr. 27];8(6-s):70-7. Available from: https://jddtonline.info/index.php/jddt/article/view/2081

How to Cite

1.
Marapur SC, Wali DS, Hunasagi BS, Chetankumar M, Patil RG. Formulation and evaluation of transdermal drug delivery system of verapamil hydrochloride. J. Drug Delivery Ther. [Internet]. 2018 Dec. 15 [cited 2025 Apr. 27];8(6-s):70-7. Available from: https://jddtonline.info/index.php/jddt/article/view/2081